v3.24.2
Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues $ 695,504 $ 545,430 $ 1,302,064 $ 1,071,108
Government grant income   47   184
Less: Interest income and other (7,832) (5,279) (13,583) (11,442)
Healthpeak’s share of unconsolidated joint venture total revenues 32,582 22,943 61,715 46,198
Healthpeak’s share of unconsolidated joint venture government grant income       229
Noncontrolling interests’ share of consolidated joint venture total revenues (9,374) (8,816) (18,413) (17,922)
Operating expenses (273,827) (221,837) (517,556) (444,925)
Healthpeak’s share of unconsolidated joint venture operating expenses (19,782) (15,754) (38,288) (32,249)
Noncontrolling interests’ share of consolidated joint venture operating expenses 2,618 2,444 5,091 5,079
Adjustments to NOI (25,232) (19,688) (52,840) (24,310)
Adjusted NOI 394,657 299,490 728,190 591,950
Plus: Adjustments to NOI 25,232 19,688 52,840 24,310
Interest income and other 7,832 5,279 13,583 11,442
Interest expense (74,910) (49,074) (135,817) (97,037)
Depreciation and amortization (283,498) (197,573) (502,717) (376,798)
General and administrative (26,718) (25,936) (50,017) (50,483)
Transaction and merger-related costs (7,759) (637) (114,979) (3,062)
Impairments and loan loss reserves, net 553 (2,607) (10,905) (394)
Gain (loss) on sales of real estate, net 122,044 4,885 125,299 86,463
Other income (expense), net 4,004 1,955 82,520 2,727
Less: Government grant income   (47)   (184)
Less: Healthpeak’s share of unconsolidated joint venture NOI (12,800) (7,189) (23,427) (14,178)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 6,756 6,372 13,322 12,843
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 155,393 54,606 177,892 187,599
Income tax benefit (expense) (2,728) (1,136) (16,426) (1,438)
Equity income (loss) from unconsolidated joint ventures 51 2,729 2,427 4,545
Net income (loss) 152,716 56,199 163,893 190,706
Corporate Non-segment        
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues 954 0 1,646 0
Government grant income   0   0
Less: Interest income and other (954) 0 (1,646) 0
Healthpeak’s share of unconsolidated joint venture total revenues 0 0 0 0
Healthpeak’s share of unconsolidated joint venture government grant income       0
Noncontrolling interests’ share of consolidated joint venture total revenues 0 0 0 0
Operating expenses 0 0 0 0
Healthpeak’s share of unconsolidated joint venture operating expenses 0 0 0 0
Noncontrolling interests’ share of consolidated joint venture operating expenses 0 0 0 0
Adjustments to NOI 0 0 0 0
Adjusted NOI 0 0 0 0
Plus: Adjustments to NOI 0 0 0 0
Interest income and other 954 0 1,646 0
Interest expense (69,856) (45,327) (107,063) (89,553)
Depreciation and amortization 0 0 0 0
General and administrative (26,718) (25,936) (50,017) (50,483)
Transaction and merger-related costs (7,264) (343) (114,290) (2,259)
Impairments and loan loss reserves, net 0 0 0 0
Gain (loss) on sales of real estate, net 0 0 0 0
Other income (expense), net 2,877 1,067 2,578 2,298
Less: Government grant income   0   0
Less: Healthpeak’s share of unconsolidated joint venture NOI 0 0 0 0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 0 0 0 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures (100,007) (70,539) (267,146) (139,997)
Income tax benefit (expense) (2,728) (1,136) (16,426) (1,438)
Equity income (loss) from unconsolidated joint ventures 0 0 0 0
Net income (loss) (102,735) (71,675) (283,572) (141,435)
Outpatient Medical | Operating Segment        
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues 332,515 186,661 570,787 373,628
Government grant income   0   0
Less: Interest income and other 0 0 0 0
Healthpeak’s share of unconsolidated joint venture total revenues 6,903 754 9,642 1,498
Healthpeak’s share of unconsolidated joint venture government grant income       0
Noncontrolling interests’ share of consolidated joint venture total revenues (9,341) (8,665) (18,217) (17,628)
Operating expenses (111,702) (65,350) (192,970) (129,749)
Healthpeak’s share of unconsolidated joint venture operating expenses (2,464) (288) (3,547) (595)
Noncontrolling interests’ share of consolidated joint venture operating expenses 2,609 2,409 5,039 5,004
Adjustments to NOI (10,430) (4,008) (16,556) (7,825)
Adjusted NOI 208,090 111,513 354,178 224,333
Plus: Adjustments to NOI 10,430 4,008 16,556 7,825
Interest income and other 0 0 0 0
Interest expense (4,070) (1,924) (26,775) (3,845)
Depreciation and amortization (173,408) (71,722) (279,699) (142,881)
General and administrative 0 0 0 0
Transaction and merger-related costs (41) (16) (154) (148)
Impairments and loan loss reserves, net 0 0 0 0
Gain (loss) on sales of real estate, net 66,831 0 70,086 21,312
Other income (expense), net 1,383 235 1,454 439
Less: Government grant income   0   0
Less: Healthpeak’s share of unconsolidated joint venture NOI (4,439) (466) (6,095) (903)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 6,732 6,256 13,178 12,624
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 111,508 47,884 142,729 118,756
Income tax benefit (expense) 0 0 0 0
Equity income (loss) from unconsolidated joint ventures (2,922) 184 (4,032) 374
Net income (loss) 108,586 48,068 138,697 119,130
Lab | Operating Segment        
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues 214,266 223,306 438,027 428,770
Government grant income   0   0
Less: Interest income and other 0 0 0 0
Healthpeak’s share of unconsolidated joint venture total revenues 4,301 1,928 9,162 4,093
Healthpeak’s share of unconsolidated joint venture government grant income       0
Noncontrolling interests’ share of consolidated joint venture total revenues (33) (151) (196) (294)
Operating expenses (56,656) (54,832) (113,496) (112,397)
Healthpeak’s share of unconsolidated joint venture operating expenses (1,528) (848) (2,852) (2,030)
Noncontrolling interests’ share of consolidated joint venture operating expenses 9 35 52 75
Adjustments to NOI (13,289) (14,943) (34,724) (15,776)
Adjusted NOI 147,070 154,495 295,973 302,441
Plus: Adjustments to NOI 13,289 14,943 34,724 15,776
Interest income and other 0 0 0 0
Interest expense 0 0 0 0
Depreciation and amortization (75,947) (93,235) (154,855) (168,817)
General and administrative 0 0 0 0
Transaction and merger-related costs (478) 0 (486) (158)
Impairments and loan loss reserves, net 0 0 0 0
Gain (loss) on sales of real estate, net 55,213 0 55,213 60,498
Other income (expense), net 185 (2) 79,168 2
Less: Government grant income   0   0
Less: Healthpeak’s share of unconsolidated joint venture NOI (2,773) (1,080) (6,310) (2,063)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 24 116 144 219
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 136,583 75,237 303,571 207,898
Income tax benefit (expense) 0 0 0 0
Equity income (loss) from unconsolidated joint ventures 2,247 1,314 5,059 1,911
Net income (loss) 138,830 76,551 308,630 209,809
CCRC | Operating Segment        
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues 140,891 130,184 279,667 257,268
Government grant income   47   184
Less: Interest income and other 0 0 0 0
Healthpeak’s share of unconsolidated joint venture total revenues 0 0 0 0
Healthpeak’s share of unconsolidated joint venture government grant income       0
Noncontrolling interests’ share of consolidated joint venture total revenues 0 0 0 0
Operating expenses (105,469) (101,655) (211,090) (202,779)
Healthpeak’s share of unconsolidated joint venture operating expenses 0 0 0 0
Noncontrolling interests’ share of consolidated joint venture operating expenses 0 0 0 0
Adjustments to NOI (1,739) (728) (1,739) (678)
Adjusted NOI 33,683 27,848 66,838 53,995
Plus: Adjustments to NOI 1,739 728 1,739 678
Interest income and other 0 0 0 0
Interest expense (984) (1,823) (1,979) (3,639)
Depreciation and amortization (34,143) (32,616) (68,163) (65,100)
General and administrative 0 0 0 0
Transaction and merger-related costs 24 (278) (49) (497)
Impairments and loan loss reserves, net 0 0 0 0
Gain (loss) on sales of real estate, net 0 0 0 0
Other income (expense), net (479) 674 (718) 7
Less: Government grant income   (47)   (184)
Less: Healthpeak’s share of unconsolidated joint venture NOI 0 0 0 0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 0 0 0 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures (160) (5,514) (2,332) (14,740)
Income tax benefit (expense) 0 0 0 0
Equity income (loss) from unconsolidated joint ventures 0 0 0 0
Net income (loss) (160) (5,514) (2,332) (14,740)
Other Non-reportable | Operating Segment        
Segment Reporting Information, Revenue for Reportable Segment [Abstract]        
Total revenues 6,878 5,279 11,937 11,442
Government grant income   0   0
Less: Interest income and other (6,878) (5,279) (11,937) (11,442)
Healthpeak’s share of unconsolidated joint venture total revenues 21,378 20,261 42,911 40,607
Healthpeak’s share of unconsolidated joint venture government grant income       229
Noncontrolling interests’ share of consolidated joint venture total revenues 0 0 0 0
Operating expenses 0 0 0 0
Healthpeak’s share of unconsolidated joint venture operating expenses (15,790) (14,618) (31,889) (29,624)
Noncontrolling interests’ share of consolidated joint venture operating expenses 0 0 0 0
Adjustments to NOI 226 (9) 179 (31)
Adjusted NOI 5,814 5,634 11,201 11,181
Plus: Adjustments to NOI (226) 9 (179) 31
Interest income and other 6,878 5,279 11,937 11,442
Interest expense 0 0 0 0
Depreciation and amortization 0 0 0 0
General and administrative 0 0 0 0
Transaction and merger-related costs 0 0 0 0
Impairments and loan loss reserves, net 553 (2,607) (10,905) (394)
Gain (loss) on sales of real estate, net 0 4,885 0 4,653
Other income (expense), net 38 (19) 38 (19)
Less: Government grant income   0   0
Less: Healthpeak’s share of unconsolidated joint venture NOI (5,588) (5,643) (11,022) (11,212)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI 0 0 0 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 7,469 7,538 1,070 15,682
Income tax benefit (expense) 0 0 0 0
Equity income (loss) from unconsolidated joint ventures 726 1,231 1,400 2,260
Net income (loss) $ 8,195 $ 8,769 $ 2,470 $ 17,942